China Renaissance-backed Bloomage Biotech raises $338m in Shanghai IPO

China Renaissance-backed Bloomage Biotech raises $338m in Shanghai IPO

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter